A retrospective multicenter study comparing the efficacy of mono versus combination therapy of Ustekinumab in patients with Inflammatory Bowel Disease
Latest Information Update: 21 Dec 2021
At a glance
- Drugs Methotrexate (Primary) ; Ustekinumab (Primary)
- Indications Crohn's disease; Pouchitis; Proctitis; Ulcerative colitis
- Focus Therapeutic Use
- 21 Dec 2021 New trial record
- 27 Oct 2021 Primary endpoint (Differences in rates of clinical remission between the UST combination and monotherapy) has not been met as per results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2021
- 27 Oct 2021 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2021